The coexistence of MAFLD increases fibrosis burden in patients with chronic hepatitis B.

Mostafa AM, Fouad Y, Abdelkader NA, Magdy O, Raouf NR, Eslam M

Open source

DOI
10.1038/s41598-026-58144-3
Published
2026 Jun 25
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-026-58144-3,
  title = {The coexistence of MAFLD increases fibrosis burden in patients with chronic hepatitis B.},
  author = {Mostafa AM and Fouad Y and Abdelkader NA and Magdy O and Raouf NR and Eslam M},
  year = {2026},
  journal = {Scientific reports},
  doi = {10.1038/s41598-026-58144-3},
  url = {https://doi.org/10.1038/s41598-026-58144-3}
}

RIS

TY  - JOUR
TI  - The coexistence of MAFLD increases fibrosis burden in patients with chronic hepatitis B.
AU  - Mostafa AM
AU  - Fouad Y
AU  - Abdelkader NA
AU  - Magdy O
AU  - Raouf NR
AU  - Eslam M
PY  - 2026
JO  - Scientific reports
DO  - 10.1038/s41598-026-58144-3
UR  - https://doi.org/10.1038/s41598-026-58144-3
ER  - 

APA

AM, M., Y, F., NA, A., O, M., NR, R., & M, E. (2026). The coexistence of MAFLD increases fibrosis burden in patients with chronic hepatitis B.. Scientific reports. https://doi.org/10.1038/s41598-026-58144-3

Source records